Cover Image for Corporate Insight Session #1 - Bayer Co.Lab

Presented by

JUNI is the springboard for science-based startups in Berlin & Brandenburg. We give you the platform, leverage and direct access to our business partners to turn your invention into a market leader.

Hosted By

Tech

Featured in

Berlin

Corporate Insight Session #1 - Bayer Co.Lab

Name: Corporate Insight Session #1 - Bayer Co.Lab
Start: 2026-08-11T18:00:00.000+02:00
End: 2026-08-11T20:00:00.000+02:00
Location: Chausseestraße 8

JUNI

Chausseestraße 8

Berlin, Germany

Approval Required

Your registration is subject to host approval.

Welcome! To join the event, please register below.

About Event

Curious how a global corporate backs science-driven startups?

Join the first Corporate Insight Session with Bayer Co.Lab and get an inside look at one of the world's leading corporate innovation ecosystems — and the opportunities it holds for researchers and aspiring founders.

Designed for postdocs, researchers, and early-stage entrepreneurs, the session shows how Bayer partners with innovative startups, supports the commercialization of scientific research, and helps founders accelerate their journey. You will get first-hand insights into Bayer Co.Lab's programs, partnership opportunities, and resources — and the chance to put your questions directly to our guest.

Whether you're already building a startup or just starting to explore entrepreneurship: this session gives you a rare look behind the scenes of corporate innovation. Join us and find out what it could mean for your own path!

Agenda
17:30 Welcome to the JUNI Campus
18:00 Who is Bayer Co.Lab with Ruth Shah?
18:30 Q&A
19:00 Drinks & Conversations

Special guest: Ruth Shah

Ruth Shah is Head of Bayer Co.Lab Berlin, a global incubator network supporting biopharma startups with labs, infrastructure, and expert access to help founders turn ideas into innovations. In 2025, she was named one of Berlin’s Top 40 under 40 for her impact on innovation and the economy. Previously, she led Bayer’s strategic initiatives in gene editing.

Location